NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
23.55
+0.13 (0.56%)
At close: Jan 17, 2025, 4:00 PM
25.00
+1.45 (6.16%)
Pre-market: Jan 21, 2025, 5:07 AM EST
NAMS Market Cap
NAMS has a market cap or net worth of $2.52 billion as of January 21, 2025. Its market cap has increased by 153.72% in one year.
Market Cap
2.52B
Enterprise Value
2.10B
1-Year Change
153.72%
Ranking
Category
Stock Price
$23.55
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.52B, an increase of 1,532.32%. That is a compound annual growth rate of 103.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 2.52B | -8.37% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |